124 related articles for article (PubMed ID: 23672878)
1. Farnesyltransferase inhibitor R115777 protects against vascular disease in uremic mice.
Nikolov IG; Joki N; Galmiche A; Nguyen-Khoa T; Guerrera IC; Guillonneau F; Ivanovski O; Phan O; Maizel J; Marçon F; Benchitrit J; Lucas A; Edelman A; Lacour B; Drüeke TB; Massy ZA
Atherosclerosis; 2013 Jul; 229(1):42-51. PubMed ID: 23672878
[TBL] [Abstract][Full Text] [Related]
2. Farnesyltransferase inhibitor, manumycin a, prevents atherosclerosis development and reduces oxidative stress in apolipoprotein E-deficient mice.
Sugita M; Sugita H; Kaneki M
Arterioscler Thromb Vasc Biol; 2007 Jun; 27(6):1390-5. PubMed ID: 17363690
[TBL] [Abstract][Full Text] [Related]
3. Lanthanum carbonate, like sevelamer-HCl, retards the progression of vascular calcification and atherosclerosis in uremic apolipoprotein E-deficient mice.
Nikolov IG; Joki N; Nguyen-Khoa T; Guerrera IC; Maizel J; Benchitrit J; Machado dos Reis L; Edelman A; Lacour B; Jorgetti V; Drüeke TB; Massy ZA
Nephrol Dial Transplant; 2012 Feb; 27(2):505-13. PubMed ID: 21705467
[TBL] [Abstract][Full Text] [Related]
4. Uremia accelerates both atherosclerosis and arterial calcification in apolipoprotein E knockout mice.
Massy ZA; Ivanovski O; Nguyen-Khoa T; Angulo J; Szumilak D; Mothu N; Phan O; Daudon M; Lacour B; Drüeke TB; Muntzel MS
J Am Soc Nephrol; 2005 Jan; 16(1):109-16. PubMed ID: 15563564
[TBL] [Abstract][Full Text] [Related]
5. Sevelamer prevents uremia-enhanced atherosclerosis progression in apolipoprotein E-deficient mice.
Phan O; Ivanovski O; Nguyen-Khoa T; Mothu N; Angulo J; Westenfeld R; Ketteler M; Meert N; Maizel J; Nikolov IG; Vanholder R; Lacour B; Drüeke TB; Massy ZA
Circulation; 2005 Nov; 112(18):2875-82. PubMed ID: 16267260
[TBL] [Abstract][Full Text] [Related]
6. The calcimimetic R-568 retards uremia-enhanced vascular calcification and atherosclerosis in apolipoprotein E deficient (apoE-/-) mice.
Ivanovski O; Nikolov IG; Joki N; Caudrillier A; Phan O; Mentaverri R; Maizel J; Hamada Y; Nguyen-Khoa T; Fukagawa M; Kamel S; Lacour B; Drüeke TB; Massy ZA
Atherosclerosis; 2009 Jul; 205(1):55-62. PubMed ID: 19118829
[TBL] [Abstract][Full Text] [Related]
7. The antioxidant N-acetylcysteine prevents accelerated atherosclerosis in uremic apolipoprotein E knockout mice.
Ivanovski O; Szumilak D; Nguyen-Khoa T; Ruellan N; Phan O; Lacour B; Descamps-Latscha B; Drüeke TB; Massy ZA
Kidney Int; 2005 Jun; 67(6):2288-94. PubMed ID: 15882270
[TBL] [Abstract][Full Text] [Related]
8. Atherosclerosis and vascular calcification in uraemia - a new experimental model.
Ivanovski O; Nikolov IG; Drueke BT; Massy AZ
Prilozi; 2007 Dec; 28(2):11-24. PubMed ID: 18356775
[TBL] [Abstract][Full Text] [Related]
9. Advanced glycation end-product Nε-carboxymethyl-Lysine accelerates progression of atherosclerotic calcification in diabetes.
Wang Z; Jiang Y; Liu N; Ren L; Zhu Y; An Y; Chen D
Atherosclerosis; 2012 Apr; 221(2):387-96. PubMed ID: 22305260
[TBL] [Abstract][Full Text] [Related]
10. Cardiovascular effects of uremia in apolipoprotein E-deficient mice.
Bro S
Dan Med Bull; 2009 Nov; 56(4):177-92. PubMed ID: 19939336
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of FOXO1/3 promotes vascular calcification.
Deng L; Huang L; Sun Y; Heath JM; Wu H; Chen Y
Arterioscler Thromb Vasc Biol; 2015 Jan; 35(1):175-83. PubMed ID: 25378413
[TBL] [Abstract][Full Text] [Related]
12. Effect of simvastatin in apolipoprotein E deficient mice with surgically induced chronic renal failure.
Ivanovski O; Szumilak D; Nguyen-Khoa T; Nikolov IG; Joki N; Mothu N; Maizel J; Westenfeld R; Ketteler M; Lacour B; Drüeke TB; Massy ZA
J Urol; 2008 Apr; 179(4):1631-6. PubMed ID: 18295249
[TBL] [Abstract][Full Text] [Related]
13. Phosphate-induced autophagy counteracts vascular calcification by reducing matrix vesicle release.
Dai XY; Zhao MM; Cai Y; Guan QC; Zhao Y; Guan Y; Kong W; Zhu WG; Xu MJ; Wang X
Kidney Int; 2013 Jun; 83(6):1042-51. PubMed ID: 23364520
[TBL] [Abstract][Full Text] [Related]
14. Phosphate binders prevent phosphate-induced cellular senescence of vascular smooth muscle cells and vascular calcification in a modified, adenine-based uremic rat model.
Yamada S; Tatsumoto N; Tokumoto M; Noguchi H; Ooboshi H; Kitazono T; Tsuruya K
Calcif Tissue Int; 2015 Apr; 96(4):347-58. PubMed ID: 25511229
[TBL] [Abstract][Full Text] [Related]
15. The farnesyltransferase inhibitor R115777 reduces hypoxia and matrix metalloproteinase 2 expression in human glioma xenograft.
Delmas C; End D; Rochaix P; Favre G; Toulas C; Cohen-Jonathan E
Clin Cancer Res; 2003 Dec; 9(16 Pt 1):6062-8. PubMed ID: 14676133
[TBL] [Abstract][Full Text] [Related]
16. Effect of Farnesyltransferase Inhibitor R115777 on Mitochondria of Plasmodium falciparum.
Ha YR; Hwang BG; Hong Y; Yang HW; Lee SJ
Korean J Parasitol; 2015 Aug; 53(4):421-30. PubMed ID: 26323840
[TBL] [Abstract][Full Text] [Related]
17. Overexpression of c1q/tumor necrosis factor-related protein-3 promotes phosphate-induced vascular smooth muscle cell calcification both in vivo and in vitro.
Zhou Y; Wang JY; Feng H; Wang C; Li L; Wu D; Lei H; Li H; Wu LL
Arterioscler Thromb Vasc Biol; 2014 May; 34(5):1002-10. PubMed ID: 24578384
[TBL] [Abstract][Full Text] [Related]
18. Stimulatory effects of cardiotrophin 1 on atherosclerosis.
Konii H; Sato K; Kikuchi S; Okiyama H; Watanabe R; Hasegawa A; Yamamoto K; Itoh F; Hirano T; Watanabe T
Hypertension; 2013 Nov; 62(5):942-50. PubMed ID: 24041953
[TBL] [Abstract][Full Text] [Related]
19. Vascular Calcification in Uremia: New-Age Concepts about an Old-Age Problem.
Smith ER
Methods Mol Biol; 2016; 1397():175-208. PubMed ID: 26676134
[TBL] [Abstract][Full Text] [Related]
20. Farnesyltransferase inhibitor R115777 inhibits cell growth and induces apoptosis in mantle cell lymphoma.
Rolland D; Camara-Clayette V; Barbarat A; Salles G; Coiffier B; Ribrag V; Thieblemont C
Cancer Chemother Pharmacol; 2008 Apr; 61(5):855-63. PubMed ID: 17639395
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
